Profil
Dr. Mark Forman was previously employed as a Chief Medical Officer by Ventyx Biosciences, Inc., a Chief Medical Officer by Passage Bio, Inc., a Vice President by ACADIA Pharmaceuticals, Inc., and an Executive Director by Translational Medicine Accelerator.
He received his undergraduate degree from Yale University, a doctorate degree from The Rockefeller University and a doctorate degree from Duke University.
Tidigare kända positioner av Mark Forman
| Företag | Position | Slut |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2026-03-04 |
| PASSAGE BIO, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-08-02 |
| ACADIA PHARMACEUTICALS INC. | Företagsledare/Principal | 2021-01-01 |
Translational Medicine Accelerator | Direktör/Styrelseledamot | - |
Mark Formans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Kopplade företag
| Privata företag | 7 |
|---|---|
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Translational Medicine Accelerator |
















